Safety Pharmacology Studies of Medicinal Products: Evaluation of Results
https://doi.org/10.30895/1991-2919-2017-7-2-92-97
Abstract
The article substantiates approaches to evaluation of results obtained in preclinical safety pharmacology studies. It describes historical background for the development of regulatory requirements and methodological recommendations for performance of such studies, provides a classification of various types of safety pharmacology studies, lays down general requirements for examination of the main battery of tests as well as subsequent and additional tests, examines the aims and main tasks of such studies, and cites examples of tests. The authors define the main scope of expert evaluation which includes the methodological basis of studies, results of studies, characterisation of a medicine’s safety profile, interpretation of preclinical data, assessment of risk factors and an anticipated clinical safety profile for patients.
About the Authors
G. N. Engalycheva
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
R. D. Syubaev
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
D. V. Goryachev
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
References
1. Guidance on evaluation of medicines. V. I. Moscow: Grif i K; 2013 (in Russian).
2. Federal Law of the Russian Federation of 12.04.2010, No. 61-FZ «On Circulation of Medicines». Available from: https://goo.gl/5KYWwR (in Russian).
3. Order of the Ministry of Health and Social Development of the Russian Federation of 26.08.2010, No. 750n «On approval of rules of expert evaluation of medicinal products for human use, and of the expert commission opinion form». Available from: https://goo.gl/wz7nMH (in Russian).
4. Order of the Ministry of Health of the Russian Federation of 13.12.2012, No. 1041n «On amendments to the Order of the Ministry of Health and Social Development of the Russian Federation of 26.08.2010, No. 750n «On approval of rules of expert evaluation of medicinal products for human use, and of the expert commission opinion form». Available from: https://goo.gl/Dt7EBm (in Russian).
5. Safety Pharmacology Studies for Human Pharmaceuticals (S7A) 2000. Available from: https://goo.gl/h2dG2M.
6. Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals (S7B) 2005. Available from: https://goo.gl/5W0wSG.
7. What is Safety Pharmacology? Available from: https://goo.gl/etRTwe.
8. State Standard R 56700 – 2015. Medicinal products for human use. Pre-clinical safety pharmacology studies. Moscow: Standartinform; 2016 (in Russian).
9. Decision of the Council of the Eurasian Economic Commission of 03.11.2016, No. 78 «On rules of registration and evaluation of medicinal products for human use». Available from: https://goo.gl/s9NsVS (in Russian).
10. Engalycheva GN, Syubaev RD, Vasiliev AN. Interpretation of class-specific effects in preclinical safety studies of drugs. Sechenovsky vestnik 2016; 2(24): 11–2 (in Russian).
11. Engalycheva GN, Syubaev RD, Vasiliev AN. Modern requirements to preclinical studies of narcological safety of neurotropic drugs. Obozrenie psihiatrii i meditsinskoy psihologii 2014; Suppl.: 74–5 (in Russian).
12. Engalycheva GN, Syubaev RD, Vasiliev AN, Snegireva AA, Verstakova OL. Preclinical safety pharmacology evaluation of medicinal products The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products 2013; (1): 10–3 (in Russian).
13. Romanov BK, Alyautdin RN, Glagolev SV, Polivanov VA. Typical pharmacovigilance system master file (PSMF). Safety and Risk of Pharmacotherapy 2016; (2): 11–27 (in Russian).
Review
For citations:
Engalycheva G.N., Syubaev R.D., Goryachev D.V. Safety Pharmacology Studies of Medicinal Products: Evaluation of Results. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2017;7(2):92-97. (In Russ.) https://doi.org/10.30895/1991-2919-2017-7-2-92-97
Views:
1041
Email this article 